Haloperidol: a promising drug repositioning for SMA
Experimental & Molecular Medicine (Nature portfolio) - OPEN ACCESS
Changes in the cortical GABAergic inhibitory system in a SMA mouse model
Cell Death and Disease - OPEN ACCESS
Enrica Boda wins the second Telethon grant
The research project aims at identifying new therapeutic targets for a rare genetic disorder, primary autosomal recessive microcephaly-17 (Mcph17).
The impact of green exposure on MDEs symptomatology
Frontiers in Psychiatry, November 2025
Depression in mice causes decreased neuronal excitability
Scientific Reports, November 2025
An Institute devoted to basic research
The main goal of NICO research center is to study the fundamental biological mechanisms of nervous system function.
Research at NICO: 10 multidisciplinary groups
Discover our research lines, international research projects we participate in and prestigius partnerships
Our excellent Laboratories & Facilities
PICO - Platform for Imaging at Cavalieri Ottolenghi: our Facility equipped with excellent quality light microscopes
RESEARCHERS
YEARS average age
PROFESSORS
% WOMEN researchers
SCIENTIFIC PUBLICATIONS per year
90
RESEARCHERS
35
YEARS
average age
30
PROFESSORS
60
% WOMEN researchers
50+
SCIENTIFIC PUBLICATIONS per year
Neuroscience Institute
Cavalieri Ottolenghi
The main goal of NICO research center is to study the fundamental biological mechanisms of nervous system function, whose knowledge is essential for the development of innovative therapeutic approaches for neurodegenerative diseases and psychiatric disorders.
News

Haloperidol induces neuroprotection and enhances neuromuscular function in both murine and human models of SMA
Our latest publication in Experimental & Molecular Medicine (Nature portfolio)
Menduti G, Perez-Gomez R, Berenger-Currias N, Ruatti C, Espinosa-Espinosa J, Januel C, Konieczny P, Artero R, Martinat C, Boido M.
NICO Research Group: Brain development and disease

Changes in the cortical GABAergic inhibitory system in a Spinal Muscular Atrophy mouse model
Cell Death and Disease, 28 February 2026
Menduti G, Ferrini F, Caretto A, Hassan A, di Vito R, Beltrando G, Marnetto D, Usiello A, Di Cunto F, Boido M, Vercelli A
NICO Research Group: Brain development and disease

Motor Neuron Diseases 2026 – IV edition
SAVE THE DATE! The fourth edition of the meeting is scheduled, again in Turin, on November 6 and 7, 2026. The conference, organized by prof. Marina Boido and Serena Stanga, will still focus on Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA), two severe neurological pathologies affecting motor neurons and causing their progressive degeneration.
Hybrid seminar
- 21/05/2026 - 2:00 pm
Researchers Area
NICO intends to provide high quality neuroscientific research, with a specific interest in prevention, diagnostics, and cure of neurological disorders.
Research Groups
Our 10 research groups with complementary approaches and experiences
Researchers
Scientific staff
Publications
Here you can find our latest scientific publications
Research projects
The list of our ongoing research projects
Lab & Facilities
PICO Platform for Imaging at Cavalieri Ottolenghi
Partnership
Partnership and networks we participate in
Support Us
Why and how to support us
Alzheimer's, multiple sclerosis and ALS (amyotrophic lateral sclerosis) are the most commonly known neurodegenerative diseases, and many families are touched, directly or indirectly, by the burdens of these diseases.